Close Menu

USPTO

Title: Compositions and Methods for siRNA Inhibition of Angiogenesis
Patent Number: 8,541,384
Filed: June 8, 2006
Lead Inventor: Michael Tolentino, University of Pennsylvania

Title: Lentiviral Transduced Dendritic Cells for RNAi
Patent Number: 8,530,153
Filed: March 10, 2011
Inventor: Sam Kam Pun Kung, University of Manitoba

Title: Method and Substances for Isolating miRNAs
Patent Number: 8,524,448
Filed: Aug. 29, 2012
Lead Inventor: Elliott Dawson, Bioventures

Title: Method of Diagnosing Poor-survival-prognosis Colon Cancer Using miR-16b
Patent Number: 8,518,647
Filed: Nov. 14, 2011
Lead Inventor: Carlo Croce, Ohio State University

Title: Methods for Diagnosing Stomach Cancer Using microRNAs
Patent Number: 8,512,951
Filed: Feb. 28, 2012
Lead Inventor: Carlo Croce, Ohio State University

Title: Methods for Diagnosing Pancreatic Cancer Using microRNAs
Patent Number: 8,507,202
Filed: Feb. 28, 2012
Lead Inventor: Carlo Croce, Ohio State University

Title: Vector
Patent Number: 8,501,466
Filed: Dec. 17, 2009
Lead Inventor: Venugopal Nair, Pirbright Institute

Title: Triggered RNAi
Patent Number: 8,497,364
Filed: Feb. 27, 2009
Lead Inventor: Niles Pierce, California Institute of Technology

Title: Dock-and-Lock Complexes for Delivery of Interference RNA
Patent Number: 8,491,914
Filed: Dec. 9, 2010
Lead Inventor: Chien-Hsing Chang, IBC Pharmaceuticals

Title: SnoRNAi-Small Nucleolar RNA Degradation by RNA Interference in Trypanosomatids
Patent Number: 8,486,910
Filed: March 12, 2012

Pages

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

The Wall Street Journal examines billing codes used by uBiome.

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.